SEMAX 10 MG
$35.00
Sale price
$35.00
Regular price
Skip to product information
SEMAX 10 MG
$35.00
Sale price
$35.00
Regular price
What is Semax?
Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH). It was originally developed in Russia and has been investigated for its potential nootropic (cognitive-enhancing), neuroprotective, and neuromodulatory effects. It is not approved by the U.S. FDA for medical use.
What is it studied for?
Semax has been studied in both preclinical and clinical research for several potential applications:
- Cognitive function and memory – Research has explored its effects on learning, memory, attention, and mental performance.
- Neuroprotection – It has been investigated for protecting neurons after conditions such as ischemic stroke and brain injury.
- Stroke recovery – In Russia and Eastern Europe, Semax has been studied as part of stroke treatment and rehabilitation protocols.
- Mood and stress resilience – Animal and early human research suggests possible effects on neurotransmitter systems involved in stress, anxiety, and mood regulation.
- Brain-derived neurotrophic factor (BDNF) – Studies indicate Semax may increase BDNF signaling, which is involved in neuronal growth and plasticity.
What is it commonly stacked with?
In research and nootropic communities, Semax is commonly discussed alongside:
- Selank – Perhaps the most common pairing, often used in cognitive and mood-focused research due to its complementary mechanisms.
- Noopept – Sometimes combined in experimental nootropic regimens aimed at memory and learning.
- NAD⁺ or NAD⁺ precursors – Frequently included in broader protocols targeting cellular energy and neurological function.
- Dihexa – Occasionally paired in experimental settings focused on synaptic plasticity and cognition.
- Cerebrolysin – Discussed in some neuroregenerative research circles for potential complementary neuroprotective effects.
- Lion’s Mane mushroom extracts and omega-3 fatty acids – Non-peptide compounds commonly combined in cognitive-support regimens.
Most of these combinations are based on community practice or theoretical synergy rather than robust clinical evidence.
Quick summary
| Topic | Summary |
|---|---|
| What is it? | Synthetic ACTH-derived heptapeptide with nootropic and neuroprotective properties under investigation |
| Primary research areas | Memory, attention, cognition, neuroprotection, stroke recovery, stress resilience |
| Common research pairings | Selank, Noopept, NAD⁺, Dihexa, Cerebrolysin, Lion’s Mane |
| Regulatory status (U.S.) | Not FDA-approved for medical use |
| Key mechanisms under study | Modulation of BDNF, dopaminergic and serotonergic pathways, and neuroprotective signaling |